MAP9 and neoplasm: Nevertheless, this suggests that underexpression of MAP9 might be of pathogenic and prognostic importance, so that this protein might have potential as a new tumor marker for colorectal cancers even though its expression does not correlate with tumor progression and as a drug target for development of new therapies.